The recent ruling (21 November 2018) of the European Court of Justice puts an end to the dispute over the off-label use of bevacizumab for age-related macular degeneration.
Perspectives
Focus on
The MEREAFAPS project (Epidemiological Monitoring of Adverse Drug Reactions and Events in Emergency Room) was launched in Lombardy in 2006. The rationale is simple: the vast majority of adverse drug reactions that occur at home take the patient to the emergency room, where doctors and nurses,...
Columns
Phytovigilance & Supplements
In recent years there has been an increase in the use of complementary and alternative medicines (CAM) in the general population, in paediatrics and also during pregnancy and lactation. This phenomenon is largely due to the fact that complementary medicine practices and even more natural products...
From regulatory agencies
| 12 April 2019 EMA | 12 April 2019 EMA |
| 04 April 2019 CADTH | 03 April 2019 FDA |
| 29 March 2019 EMA | 26 March 2019 AIFA |
| 26 March 2019 AIFA | 26 March 2019 EMA |
| 25 March 2019 AIFA | 20 March 2019 EMA |